India estimated to contribute $1.2m in 2018 (official launch is at the Feb 1 conference).
Obviously these numbers will expand quickly year by year as more surgeons take up Adapt AND as 3D etc become available.
$1.2m in 2018 is only the beginning...
Ann: Regulatory approval to launch CardioCel in India, page-69
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
0.200(1.57%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $12.62 | $12.99 | $12.61 | $210.9K | 16.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1099 | $12.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.98 | 246 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |